AlphaRose Therapeutics
Company profile on P2PMarketData. AlphaRose Therapeutics is a biotechnology company based in Austin, TX, founded in 2023. It has raised $1.6M through crowdfunding on StartEngine.
AlphaRose Therapeutics is a biotechnology company headquartered in Austin, Texas, focused on developing personalized medicine treatments for children with genetic diseases. The company works to rapidly develop and commercialize therapeutic options for patient populations with limited treatment availability. AlphaRose's lead product candidate, Rosiphersen, is in development with support from the NCATS TRND program.
Frequently asked questions about AlphaRose Therapeutics
How much funding has AlphaRose Therapeutics raised?
AlphaRose Therapeutics has raised $1.6M through crowdfunding across 1 round tracked by P2PMarketData, from 169 investors.
What is AlphaRose Therapeutics' valuation?
AlphaRose Therapeutics had an indicative valuation of $12.1M in its 2025 funding round.
Is AlphaRose Therapeutics profitable?
No. AlphaRose Therapeutics reported a net loss of $625.3K for fiscal year 2024.
How many employees does AlphaRose Therapeutics have?
AlphaRose Therapeutics reported 1 employee for fiscal year 2024.
When was AlphaRose Therapeutics founded?
AlphaRose Therapeutics was founded in October 2023.
Where is AlphaRose Therapeutics based?
AlphaRose Therapeutics is headquartered in Austin, Texas, United States, and is incorporated in Delaware, United States.
What industry is AlphaRose Therapeutics in?
AlphaRose Therapeutics operates in the Biotechnology industry within the Healthcare sector.